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ABSTRACT

Two studies were performed to determine effects of prostaglandin F2a (PGF2a)on
continued embryonic development of pre-compacted {in v/Yro-produced) and compacted
{in v/vo-derived) bovine embryos. In Experiment 1, pre-compacted (16-32 cell) in vitroproduced embryos were randomly assigned to receive either: 1) control(KSOM-PVA; n=
168); 2)PGF-1 (1 ng/mL PGF2a in KSOM-PVA; n= 143); 3)PGF-10(10 ng/mL PGF2a
in KSOM-PVA; n= 168); 4)PGF-100(100 ng/mL PGF2a in KSOM-PVA; n= 136), or 5)

PGE-5 (5 ng/mL PGE2 in KSOM-PVA; n= 62). Following four days of culture (5.5%
CO2, 7% O2, and 87.5% N2 at 38.5°C) in assigned treatments, development of embryos

was determined by experienced technicians uninformed of treatments. Continued
development of in v/Yro-produced 16- to 32-cell embryos (pre-compacted) to blastocyst
was reduced by addition of PGF2a in culture media (PGF-1, 30.4%; PGF-10, 41.4%;
PGF-100, 33.3%, and control, 51.8%; P^O.002). In addition, culture of embryos in

medium containing 1 ng/mL of PGF2a had a more detrimental effect than addition of 10
ng/mL of PGF2a {P<0.05). Furthermore, blastocyst development did not differ between
control and PGE2 treatments {P>0.10).

In Experiment 2, compacted {in v/vo-derived) glycerol-frozen embryos were
thawed and then allowed to regain normal morphology in holding medium for 30 min.

Embryos were then sorted by stage of development and quality according with lETS

guidelines for classification of bovine embryos. Compacted morula in the quality score of
1, 2 or 3(n= 436) were randomly assigned to one of four treatments: 1) control(KSOMPVA; n= 110); 2) PGF-0.1 (0.1 ng/mL PGF2a in KSOM-PVA; n=108); 3) PGF-1 (1

111

ng/mL PGF2a in KSOM-PVA; n=109); 4) PGF-10 (10 ng/mL PGF2„ in KSOM-PVA;

n=109). After 24 h in culture(5.5% CO2,7% O2, and 87.5% N2 at 38.5°C), embryos were
washed and placed in KSOM containing 0.5% BSA without PGF2a for an additional 48 h.
Embryo development was evaluated by experienced technicians uninformed of

treatments. Continued development of in v/vo-derived compacted morula to blastocyst
was not affected by addition of PGF2a to the culture medium (control, 68.1%; PGF-0.1,
58.9%; PGF-1, 61%, and PGF-10, 60%; P>010). However, hatching rates of embryos
cultured with 0.1, 1 and 10 ng/mL PGF2a were significantly lower than controls (24, 29.1,

24.5, and 44.5, respectively; P=0.05). No significant differences in hatching rates
between doses of PGF2a were observed.

In conclusion, these studies suggest a direct negative effect ofPGF2a on continued

embryonic development of pre-compacted and compacted bovine embryos. Responses to
PGF2a of pre-compacted (decreased blastocyst development) and compacted (decreased

hatching rates) embryos may involve different mechanisms of action of PGF2a depending
on stage of development. In compacted embryos, PGF2a may act through inhibiting
completion of blastocoel formation and hatching; whereas, PGF2a may have more
dramatic effects by altering compaction in pre-compacted embryos.
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CHAPTER 1
INTRODUCTION

Inadequate reproductive performance in dairy and beef cattle reduces production
efficiency and results in a profound economic impact to the cattle industry. Net calf crop

(percent of beef cows weaning a calf) in the United States has been estimated to be
between 65 to 85%(Bellows et ah, 1979), which indicates a high incidence of embryonic
or fetal wastage. Early embryonic death accounts for 75 to 80% of reproductive losses
between fertilization and calving (Sreenan and Diskin, 1983). Embryonic losses appear to
occur soon after the embryo enters the uterus (5-8 days after mating or insemination),
when the morula stage embryo is developing into blastocyst (Ayalon, 1978; Maurer and
Chenault, 1983; Wiebold, 1988; Dunne et al., 2000).

Numerous factors such as heat stress (Putney et al., 1989; Malayer et al., 1990),
nutrition (Butler, 1998), mastitis (Hockett et al., 1998), manipulation of the reproductive
tract during embryo transfer and artificial insemination (Warm and Randel, 1990; Velez
et al., 1991), and plant toxins (tall fescue; J. W. Oliver, personal communication) may
contribute to early embryonic losses through premature release of uterine luminal
concentrations of prostaglandin F2a (PGFia) in cattle. Schrick and coworkers (1993)

reported that embryo quality in beef cattle tended to be negatively correlated with
elevated uterine luminal concentrations of PGF2a- Furthermore, addition of PGF2a to

culture medium has been shown to inhibit in vitro development of rabbit (Maurer and

Beier, 1976) and rat embryos (Breuel et al., 1993a). In addition, several studies have
shown that administration of PGF2a on days 5 through 8 following artificial insemination
in cows receiving supplemental progestogen resulted in reduced pregnancy rates and
1

retarded development of embryos (Buford et al., 1996; Hockett et al., 1998; Seals et al.,
1998; Lemaster et al., 1999). These results suggest a direct and/or indirect effect of
PGF2a on embryonic survival in the cow.

The mechanisms by which PGF2a reduces embryonic survival and development
are unknown. Therefore, the objective of this thesis was to determine if direct effects of

PGF2a occur on embryonic development during culture of pre-compacted (in vitroproduced) or compacted (in vzvo-derived) bovine embryos.

CHAPTER 2

LITERATURE REVIEW

Early embryonic development

Establishment of a viable pregnancy in cattle depends on many complex

processes. Functional gametes must be produced by both sexes, the female must show
estrus, estrus must be detected by the male, mating must be completed within the

functional lifespan of the gametes, and proper uterine environment and corpus luteum
functionality must ensure embryonic and fetal development.

In the cow, a population of primordial follicles containing an oocyte arrested at
prophase of the first meiotic division (immature oocyte) is established during fetal life
(van Wezel and Rodgers, 1996). During each estrous cycle, two or three follicular waves

occur in which a group of follicles are recruited to initiate growth (Savio et al, 1988;
Ginther et al., 1989; Fortune, 1993). During each follicular wave, only one of these
follicles becomes dominant and continues to grow, while subordinate follicles regress

(Knopf et al., 1989). Upon luteolysis (destruction of the corpus luteum by PGF2a of
endometrial or exogenous origin), the dominant follicle increases size and produces
estradiol 17p to "trigger" a preovulatory peak of luteinizing hormone (LH) and estrous
behavior. Luteinizing hormone causes the oocyte in the dominant follicle to mature

(progresses to metaphase of the second meiotic division) and ovulation to take place
(Espey, 1994).

After expulsion from the ovulatory follicle, the oocyte is transported to the
oviduct. The oviduct is comprised of four distinct regions: infundibulum, ampulla,
ampullary-isthmic junction, and isthmus (reviewed by Ellington, 1991). The mature

oocyte is captured by the infundibulum and transported to the ampullary-isthmus junction

where capacitated sperm binds to the zona pellucida surrounding the oocyte, undergoes

acrosome reaction and penetrates the oocyte's plasma membrane (reviewed by Saling,
1991). After fertilization and organization of the male and female pronuclei, the zygote
becomes an embryo that undergoes a series of synchronized cell divisions (also called
cleavage divisions; Figure 2-1).

The first cleavage division generates a two-cell embryo, in which cells are called

blastomeres. As the early embryo is transported through the oviduct (isthmus region),
each blastomere undergoes subsequent divisions yielding 4-, 8-, 16- and 32-cell embryos
(Figures 2-1; 2-2). The embryo reaches the uterine horn on day 5-6 after estrus; at which
time, blastomeres flatten against each other forming a "solid ball" of cells called morula

(Figure 2-2). The morula stage embryo begins to form a fluid filled cavity (the
blastocoel) and the embryo becomes a blastocyst (Watson et al., 1992). Throughout all
these developmental stages, blastomeres become smaller with no net increase in size of

the embryo. As a result of additional fluid accumulation within the blastocoel, the
embryo starts to expand (expanded blastocyst) and finally hatches from the zona
pellucida (hatched blastocyst) on approximately day 9 after estrus(Figure 2-2; Van Soom
etal., 1997).

For attachment to the uterine endometrium, the blastocyst must hatch (escape)

from the zona pellucida (Figure 2-1). Thus, embryo hatching is a critical step for a
successful pregnancy in cattle. Furthermore, low implantation rates of in v/tro-fertilized

human embryos are largely due to impaired development and hatching of blastocyst
(Magli et al., 1998).
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Figure 2-2. Location and timing of development in bovine embryos.

The process of hatching in bovine embryos has been well documented by Massip
and Mulnard (1980). In cattle, acctimulation of fluid in the blastocoel of in v/vo-derived
embryos distends the zona pellucida (ZP), which becomes gradually thinner. Then, the

ZP breaks rapidly and hatching begins immediately by protrusion of the blastocyst
through the opening in the ZP. The ZP does not show signs of lysis but is perforated in
one location only. Moreover, zona-pellucida-intact embryos, as well as empty ZP, can be

found in uterine flushings up to day 16 after ovulation (Betteridge et al., 1980) indicating
that enzymatic lysis ofthe ZP does not occur during hatching in cattle.

The fully expanded bovine blastocyst must exert hydrostatic pressure to create a
hole in the ZP through which the blastocyst egresses. Fluid accumulation in the

blastocoel is achieved by the presence of a Na"^-K^-ATPase pump and tight junctions in
the trophectoderm epithelium. On the other hand, in vitro studies in hamsters and mouse
indicated that blastocyst expansion is followed by a focal ZP thinning preceding a focal

ZP rupture, protrusion of the embryo, and complete ZP dissolution. These findings
indicate that enzymatic degradation of the ZP is essential for hatching of hamsters and
mouse embryos (Kane and Bavister, 1988; Gonzalez and Bavister, 1995; O'Sullivan, et

al., 2001). In fact, hatching of in v/Yro-produced mouse blastocyst has been related to a
trypsin-like proteinase associated with cells of the trophectoderm (Perona and
Wassarman, 1986; Sawadaetal., 1990).

Embryonic genome activation

Maternal mRNAs and proteins accumulated in the oocyte's cytoplasm during the
growth phase within the follicle are able to support early embryonic divisions (Arends
7

and Willye, 1991). Further development is achieved by activation of the embryonic
genome, which differs in time of initiation between species: 1-cell stage in the mouse

(Aoki et al., 1997), 4-cell stage in humans(Braude et al., 1988), and 8- to 16-cell stage in
cattle (Camous et al., 1984; Figure 2-1), sheep (Crosby et al., 1988), and rabbits (Manes,
1973). The majority of maternal proteins and mRNA are degraded during transition from
matemal to embryonic genome activation (Latham et al., 1991). Memili and coworkers

(1998) suggested minor genome activation between the 1- and the late 4-cell stages and a

niajor gene activation at the 8-cell stage in bovine embryos. During embryonic genome
activation, several important genes for cell proliferation, compaction and blastocyst
formation are activated. Some of those genes include expression of growth factors and
their receptors (Rappolee et al., 1990), connexins (Kidder, 1987) and Na'^-K"' ATPase
enzyme(Watson and Kidder, 1988).

Compaction process in embryos

Compaction represents one of the first key critical events important for continued
development. It allows polarization and differentiation of blastomeres into two different
cell populations (by induction of cell adhesion molecules between blastomeres that

enhance cell communication and adherence) and facilitates fluid accumulation within the

embryo that directly contributes to blastocyst formation and subsequent hatching from
the zona pellucida (Watson et al., 1992). Compaction appears to occur in all mammalian

embryos but timing differences exist between species: mouse at 8-cell stage (Ducibella
and Anderson, 1975), humans at 16-cell stage (Edwards et al., 1981), and bovine (Van
Soom et al., 1997; Figure 2-1)and rabbit(Koyama et al., 1994)at 32-cell stage.
8

During compaction, blastomeres adhere to and flatten against each other so
boundaries cannot be recognized between cells (Van Soom et al., 1997). During this

period, development of Ca"^-dependent cell adhesion molecules such as E-cadherin and
establishment of gap and tight jimctions lead to cellular and morphogenetic
differentiation of blastomeres. Outer blastomeres polarize and form the trophectoderm

(TE), while inner blastomeres remain apolar and produce the inner cell mass (ICM;
Koyama et al., 1994). The inner cell mass forms the embryo proper and some extraembryonic membranes (allantoids and amnion); whereas, trophectoderm cells will
combine with the ICM-derived extra-embryonic membranes to form the fetal placenta
(Schlafer et al., 2000).

The free or apical membrane surfaces of the TE develop a microvillus cap with

several Na"^-dependent transport systems (Miller and Schultz, 1985; Fleming and
Johnson, 1988). These transport systems play a central role in establishment of an ion
concentration gradient across the epithelium that facilitates osmotic accumulation of

water into the blastocoelic space to form the nascent blastocoel (Diggers et al., 1988).
Basolateral surfaces of TE remain free of microvilli, but become distinguished from
apical surfaces by localization of tight junctions (Fleming et al., 1989), gap junctions
(Kidder, 1987), adherent junctions (Vestweber et al., 1987), and acquisition of an active

Na^-K^ ATPase pump (Watson et al., 1999). Even though all mammalian embryos
undergo compaction, some differences exist between in v/vo-derived and in vitroproduced bovine embryos(Van Soom et al., 1997). Both embryo types start compaction

at 32-cell stage, but compaction in in v/7ro-produced embryos is shorter and less obvious
than in in v/vo-derived embryos.
9

In summary, development of cell adhesion molecules and gap junction-mediated
interblastomeric cell communication induces cell polarization and differentiation of

undifferentiated blastomeres into TE epithelium and ICM during compaction. Moreover,

the trophectoderm develops the capacity to initiate and regulate blastocoel formation by

the action of Na^-K"^ ATPase enzyme (in the basolateral surface TE epithelium).
Additionally, presence of a junctional apical complex (formed by tight junction at the
apical part of the TE epithelium) prevents uncontrolled leakage of this fluid from the
blastocoel cavity (Watson et al., 1992).

Involvement ofcadherins in embryonic development

Cell adhesion molecules play a critical role during compaction and blastocyst
formation in the early embryo, and therefore in subsequent development and viability of
the conceptus. Cadherins are a superfamily of Ca'^-dependent adhesion molecules that
provide strong mechanical attachment between adjacent cells. Cadherin molecules have

three major domains or regions: an extracellular domain responsible for specific
recognition of the same cadherin present in neighboring cells, a transmembrane domain
that spans the cell membrane, and a cytoplasmic domain that extends into the cell and
associates with cytoplasmic proteins called catenins, which in turn bind cadherins to actin

filaments in the cytoskeleton (Ivanov et al., 2001).

In the mouse, E-cadherin is expressed in the oocyte and during the early period of
embryonic genome activation (at 2-cell stage; Vestweber et al., 1987). Also, E-cadherinmediated adhesion between blastomeres initiates compaction and plays a critical role in

differentiation of the trophectoderm and morphogenesis ofthe mouse blastocyst(Fleming
10

et al., 2001). E-cadherin is uniformly distributed on the surface of all mouse blastomeres
during early cleavage but redistributes to cell-cell contact sites upon activation at the 8cell stage (when compaction begins) suggesting post-translational regulations. In fact, Ecadherin becomes phosphorylated for the first time at compaction (Sefton et al., 1992;

Figure 2-1). Activation of PKC with phorbol ester or treatment with diacylglycerides
caused 4-cell mouse embryos to compact ahead of normal timing, while PKC inhibitors
prevented compaction (Winkel et al., 1990). Moreover, mouse embryos lacking Ecadherin and alpha catenin failed to generate a normal trophectoderm and died before
implantation (Laure et al., 1994; Riethmacher et al., 1995). In cattle, E-cadherin is evenly
distributed around cell margins of 1-cell zygotes and cleavage stage embryos and
becomes restricted to basolateral membranes of trophectoderm cells during morula stage,
while maintaining apolar distributions in the ICM (Barcroft et al., 1998).

Role ofgapjunctions in embryonic development

Gap junctions are channels present in opposing plasma membranes of neighboring
cells (Kidder and Winterghager, 2001). The cell membranes come close together, but are
separated by 2-4 nanometers. These junctions are composed of at least 13 different

proteins called connexins (Bruzzone and Goodenough, 1996; De Sousa et al., 1997);
however, several studies identified connexin 43 as the most important gap junctional

protein expressed in mouse (De Sousa et al., 1993; Valdimarsson and Kidder, 1995),

bovine (Wrenzycki et al., 1996; 1999), and rat (Reuss et al., 2002) preimplantation
embryos.
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Intercellular communication through gap junctions is believed to be essential for

cellular growth, cellular differentiation and development (Warner, 1992; Zhang and
Thorgeirsson, 1994). Recently, a targeted gene inactivation approach has been used to

explore the functional significance of connexin diversity. For example, connexin 26 is

expressed in the labyrinth of the mouse placenta and its absence causes impaired
metabolite transfer from maternal blood to the developing embryo, leading to death in

mid-gestation (Gabriel et al., 1998). Female mice lacking cormexin 37, which is present
in the ovary, develop a block in ovarian follicular development and are sterile (Simon et

al., 1997). Although connexin 43 is the most widely expressed connexin, offspring
lacking connexin 43 survive until birth and die soon after as a result of morphological
heart defects (Reaume et al., 1995), but they do not show any other abnormalities when

compared to animals with normal expression of connexin 43. De Sousa et al. (1997)
showed that preimplantation mouse embryos deficient in connexin 43 retained the

capacity for cell-to-cell transfer of fluorescent dye (dye coupling), but at a severely
reduced dye coupling. Researchers suggested that loss of connexin 43 can be

compensated by other connexins such as connexin 45, a protein also assembled into
membrane plaques at the time of compaction.

At the plasma membrane, six copies of the same connexin form a hexagonal ring-

shaped channel called connexon. Connexons in adjacent cell membranes align together to
form a hydrophilic channel that allows passage of ions and small molecules such as

cyclic AMP, Ca"^ and inositol tri-phosphate (IP3) between cells and thereby coordinate
metabolic and electrical activities (Lowenstein, 1981). Studies using Lucifer yellow have

shown that blastomeres of in vivo- and in v/Yro-produced mouse embryos are coupled by
12

functional gap junctions(De Sousa et al., 1993). Boni et al.(1999) showed that diffusion
of dye between ICM cells started at morula stage in in v/vo-derived and at the blastocyst
stage in in vZ/ro-produced bovine embryos. In the same study, gap junctions were found
in the ICM as well as between ICM and TE, but not between TE cells of in v/7ro-derived

embryos. However, gap junctions were present through all cells and in a higher density in
in v/vo-derived embryos.

Although assembly of functional gap junctions in mammalian preimplantation

embryos is a temporally regulated event occurring during compaction (Figure 2-1), both
mRNA and protein corresponding to connexin 43 are being synthesized as early as the 4cell stage in mouse embryos (one cell cycle before compaction; De Sousa et al., 1993).

Injection of gap junction antisense RNA to 2- and 4-cell mouse embryos reduced the
percentage of compacted embryos to less than 20%, while 90% of uninjected embryos
compacted (Bevilacqua et al., 1989). Also, when the same antisense was injected to 8-cell
stage mouse embryos, only 5% of the embryos developed to blastocyst stage, while
blastulation occurred in 90% of control embryos. Similarly, injection of gap junction
antibodies inhibited dye transfer and dramatically reduced electrical coupling of 8-cell
mouse embryos(Lee et al., 1987).

In mouse embryos, De Sousa et al. (1993) demonstrated that connexin 43 shows
different localization between blastomeres of morula and blastocyst embryos: a zonular

distribution predominated between outside blastomeres and trophectoderm cells;
whereas, plaque-like localizations predominated between inside blastomeres and cells of
the inner cell mass. In the same study, treatment of uncompacted 8-cell mouse embryos

with monensin or brefeldin-A (inhibitors of protein trafficking) prevented the appearance
13

of gap junction-like structures. In another study, inhibition of DNA synthesis with
aphidicolin during the third and fourth cell cycles of mouse embryos had no affect on

establishment of gap junctional coupling, but administration of aphidicolin for 10 h
during the second cell cycle resulted in failure of gap junctional coupling (Valdimarsson

and Kidder, 1995). Thus, timing of gap junctional coupling is linked to DNA replication
in the 2-cell mouse embryo in the mouse.

Data on intercellular communication through gap junctions in early bovine
embryos are limited. Utilizing polymerase chain reaction (PGR), Wrenzycki and
colleagues (1996) reported that transcripts for connexin 43 were present in immature

oocytes and all developmental stages of in v/Yro-produced embryos through morula stage;
whereas, only in v/vo-derived morula and blastocyst stages expressed connexin 43. This
findings correlate with reports from Prather et al. (1993) reporting that in v/vo-derived

morula and blastocyst embryos showed dye transfer indicating the existence of gap

junctions, while in vfrro-produced morula and blastocyst embryos did not show spreading
of dye.

In cultured vascular cells, gap junctional intercellular communication is inhibited

by PKC-dependent excessive phosphorylation of connexin 43, which is the primary gap
junction in vascular cells. In addition, excessive phosphorylation of the same protein

induces impairment of ventricular conduction in the heart (Inoguchi et al., 2001).
Furthermore, Criswell(1995) demonstrated that high intracellular levels of Ca"^, addition

of Ca"^ ionophore 4-br-A23187, increased PKC activity and inclusion of TPA (an
activator of PKC) resulted in inhibition of gap junctional communication in cultured
uterine smooth muscle cells.
14

Importance ofTightjunctions in embryonic development

Tight junctions (zonula occludens) seal the trophectoderm epithelium in a narrow
band just beneath their apical surfaces and right above zonula adherens junctions. Tight
junctions represent a site of close intercellular adhesion including partial membrane
fusion that forms a barrier against paracellular diffusion, generates a trans-epithelial
resistance, and allows blastocoel formation (Diggers et al., 1988). Tight junctions

comprise several proteins(both transmembrane and cytoplasmic) with the most important
being zonula occludens 1 (ZO-1)and cingulin (Citi, 1993), which are only present within
the trophectoderm. Following compaction, polar cells adhere to and gradually envelope
nonpolar cells causing ZO-1 in the nonpolar cells to disappear. Thus, symmetrically cell
contact appears to initiate ZO-1 down regulation in the ICM lineage (Fleming and Hay,
1991). In cattle, ZO-1 is undetectable until the morula stage when it first appears as
punctuate points between outer cells (Barcroft et al., 1998; Figure 2-1). In the blastocyst,
ZO-1 is localized as a continuous ring at the apical points of trophectoderm cell contact,
whereas it remains undetectable in the ICM.

Although tight junction formation does not begin until compaction of the 8-cell
stage mouse embryo (a process dependent upon E-cadherin activation), immunoblotting
of unfertilized eggs and preimplantation mouse embryos showed high levels of cingulin
in eggs and early cleavage stages, a decline during later cleavage, and an increase in
cingulin levels during the stage of expanding blastocyst (Javed et al., 1993). In cattle,
ZO-1 is undetectable until morula stage when first appears as punctuate points between

outer cells. In the blastocyst, ZO-1 is localized as a continuous ring at the apical points of
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trophectoderm cell contact, whereas remains undetectable in the ICM (Barcroft et al.,
1998).

Cell death during embryonic development

Cell death occurs as a normal feature of early embryonic development in both in
vivo and in vitro-dehved embryos (Jurisicova et al., 1996; Hardy, 1997; Matwee et al.,
2000). Two forms of cell death can be distinguished based on morphological and
molecular criteria (Willye et al., 1980; Granville et al., 1998).

Necrosis is characterized by nuclear disintegration, cellular swelling, rupture of

internal and external membranes with release of lytic enzymes, and damage to
surrounding cells by stimulation of an inflammatory reaction (Majno and Joris, 1995).
Necrosis is considered to be an "accidental" cell death initiated by gross environmental

insults such as severe hypoxia, heat shock and exposure to metabolic toxins (Willye et

al., 1980). In contrast, apoptosis (also called programmed cell death) occurs in single
rather than groups of cells and is thought to be a self-directed death or "cell suicide" to

assure normal development and differentiation by removal of damaged or defective cells
(Edwards, 1998).

Apoptosis is characterized by a series of morphological changes. First, chromatin
aggregates into large compact granular masses on the inner nuclear membrane, the
cytoplasm condenses and the nuclear and cytoplasmic membranes became indented.

Then, DNA fragments and the nucleus separate into discrete masses. During the final
phases of the apoptotic processes there is extensive blebbing of the plasma membrane
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with the formation of membrane-boimd apoptotic bodies, which can be phagocytosed by
surrounding cells or extruded into an adjacent lumen (Willye et al., 1980).

In addition to morphological changes, biochemical alterations at the plasma
membrane or at the DNA structure are also observed. In the earliest stages of apoptosis,
phosphatidyl-serine, a membrane phospholipid generally associated to the inner

cytoplasmic leaflet, is exposed to the outer leaflet and promotes phagocytosis by
neighboring cells (Martin et al., 1995). This feature is useful in determining apoptosis by

utilizing the anticoagulant, protein annexin V, which has a specific and high affinity for
phosphatidyl-serine. Healthy cells incubated in fluorescein isothiocyanate (FITC)conjugated armexin V remain unlabelled, as aimexin V can not access to the inner leaflet

of the plasma membrane. However, cells undergoing apoptosis show a marked increase
in annexin V binding, indicating that phosphatidyl-serine is translocated to the outer
leaflet(Martin et al., 1995).

Rounding and separation of apoptotic cells from neighboring cells is associated to

a lack of gap jimction communication between cells (Hardy et al., 1996).
Deoxyribonucleic acid between nucleosomes is cleaved by endonucleases into
oligonucleosomal fragments (Arends and Willye, 1991; Rueda et al., 1995). These

fragments can be visualized as a typical "DNA ladder" with bands at 180-200 bp
intervals by agarose gel electrophoresis.

Due to the small number of cells in preimplantation embryos, it is impossible to

use electrophoretic techniques to observe for DNA laddering typical of apoptotic nucleus

(Hardy, 1999). Fortunately, development of TdT-mediated dUTP nick-end labelling
(TUNEL) enables assessment of nuclear DNA fragmentation in situ (Gavrieli et al.,
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1992). Matwee et al. (2000) observed TUNEL labelling in bovine oocytes, 8- to 16-cell
embryos, morula, and blastocyst stage embryos, but labelling was not observed in
zygotes or early cleavage stage embryos. Similar results were observed in human

(Jurisicova et al., 1996) and porcine embryos (Long et al., 1998) suggesting that
occurrence of apoptosis is dependent on developmental stage of the embryo and early
stage embryos (before compaction) seem to be more resistant to apoptosis than later
stages.

Levels of transcripts involved in the apoptotic pathway might be below a specific
threshold before embryonic genome activation and cellular differentiation into the

trophectoderm and inner cell mass. Undifferentiated tissues during fetal development in
humans possess an inhibitor of caspases activity (Adida et al., 1998). Early stage bovine
embryos may possess a similar mechanism (matemally produced proteins and mRNA)to
avoid apoptosis until morula stage. Apoptosis may also be an efficient mechanism to

eliminate blastomeres that did not begin transcription of the embryonic genome after the
8-ceIl stage in cattle.

Prostaglandin synthesis and action

Prostaglandins are biochemical compounds derived from the polyunsaturated fatty

acid, arachidonic acid. Prostaglandins are involved in several physiological processes
such as inflammation, production of pain and fever, control of blood vessel tone and

arterial blood pressure, luteolysis, and blood clotting (Nett et al., 1976; Seibert et al.,
1994; Blatteis and Sehic, 1997). With the exemption of red blood cells, prostaglandins
are synthesized and released by all mammalian cells and tissues. However, imlike other
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hormones, prostaglandins are not stored in cells but are produced and released
immediately after stimulation (Bito, 1975).

Phospholipase A2 (PLA2) catalyzes the hydrolysis of the sn-2 position of

membrane glycerophospholipids to liberate arachidonic acid (AA), a precursor of

eicosanoids including prostaglandins and leukotrienes. So far, at least 19 enzymes that
possess PLA2 activity have been identified in mammals (reviewed by Murakami and

Kudo, 2002). Since arachidonic acid contains 20 carbon atoms, prostaglandins are

referred to eicosanoids. Arachidonic acid is derived from membrane phospholipids
primarily by the action of cytoplasmic phospholipase A2 (Flint et al., 1986). This

cleavage state is the rate-limiting step in prostaglandin synthesis (Figure 2-3). Free
arachidonic acid is then converted to prostaglandin H2 (PGH2) by the action of

cyclooxygenase enzymes at the membranes of the endoplasmic reticulum (Smith and
DeWitt, 1996)or the nucleus (Parfenova et al., 2001).

There are two forms of cyclooxygenase: COX-1, a constitutive enzyme found in

almost all cells; and COX-2, an inducible form in response to inflammatory reactions,
hormonal and environmental stimulus (Smith and DeWitt, 1996). Cyclooxygenase-1 and
-2 catalyze the conversion of free arachidonic acid to PGH2 by two sequential enzymatic
steps: oxygenation, which converts free arachidonic acid to the unstable intermediate

PGG2, followed by a peroxidation that converts PGG2 to PGH2 (Smith and DeWitt,
1996).

Different specific enzymes, whose presence varies depending on the cell type,
mediate formation of the D, E, I, and F series from PGH2 in different tissues.
Prostaglandin production can be blocked by administration of nonsteroidal anti19
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Figure 2-3. Schematic representation of prostaglandin Fj^ynthesis.

inflammatory drugs(NSAIDs)such as aspirin, indomethacin and phenylbutazone and by
steroidai anti-inflammatory drugs like hydrocortisone, prednisone and prednisolone.
Nonsteroidal anti-inflammatory drugs act through inhibition of COX-1 and COX-2(Vane
and Dotting, 1996), while steroidai anti-inflammatory drugs interfere with mobilization of

arachidonic acid from the plasma membrane by inhibition of phospholipase A2(Rothhut
and Russo-Marie, 1984).

Mechanism ofaction ofPGF2a

In nonpregnant cows, PGF20, is released from the uterus in a pulsatile manner to
cause regression of the corpus luteum (Kindahl et al., 1976) and allows ovulation of the
dominant follicle. Oxytocin stimulates uterine secretion of PGF2a when administered in

vivo (Silvia and Taylor, 1989) and in vitro (Lafrance and Goff, 1990). Oxytocin released
from large luteal cells binds to its receptors in the uterus endometrium and stimulates

uterine secretion of PGF2a by activation of phoslipase A2 and conversion of arachidonic

acid to PGF2a. Then, uterine PGF2a stimulates further oxytocin release from the corpus
luteum (CL; Flint and Sheldrick, 1982). Thus, a positive feedback loop between PGF2a

and oxytocin seems responsible for the generation of each pulse of PGF2a during
luteolysis.

The PGF2a receptor is a seven transmembrane G-protein coupled receptor
(Sakamoto et al., 1994). After binding to its receptor, PGF2a activates a membrane-bound

phospholipase C, which causes hydrolysis of membrane phosphatidylinositol bi-

phosphate (PIP2) to inositol triphosphate (IP3) and diacylglycerol (DAG) (Berridge,
1987). Increased concentrations of IP3 result in a release of free Ca"^ from intracellular
21

stores to the cytosol, while DAG enhances the affinity of protein kinase C (PKC) for
Ca"^, which results in PKC activation.

Although information regarding the presence of PGFaa receptors in early stage
embryos has not been found in the literature, the bovine CL represents an excellent model
for understanding the mechanisms of action of PGF2a. Protein kinase C is believed to

mediate many of the antisteroidogenic actions of PGF2a in large luteal cells (McGuire et
al., 1994). In addition to this, PGF2a may interfere with the ability of LH to activate PKA,
an enzyme needed for phosphorylation and stimulation of other key enzymes in the luteal

steroidogenic pathway, such as cholesterol esterase (hydrolyzes the stored cholesterol)
and steroidogenic acute regulatory protein (StAR), which transports cholesterol to the

mitochondria (Garverick et al., 1985). In contrast to early signaling events, downstream

signals in response to PGF2a are poorly understood. Chen et al. (1998) reported that

PGF2a activates the Raf/Mekl/mitogen-activated protein kinase (MAPK) signaling
cascade in bovine luteal cells. Therefore, signals on the cell surface may be responsible
for transcription of luteal genes.

Prostaglandin F2a promotes apoptosis in luteal cells by activation of

endonucleases after influx of Ca"^ from intracellular stores (Juengel et al., 1993). Also
during luteolysis in cattle, mRNA encoding Bax (a pro-apoptotic gene) is elevated
resulting in an increased ratio of Bax to Bcl-2 (anti-apoptotic gene), an event consistent
with Bax-mediated apoptosis (Rueda et al., 1997). Prostaglandin F2a also induces

apoptosis in luteal cells by generation of oxygen radicals such as superoxide anion,
hydroxyl radical and hydrogen peroxide (Riley and Behrman, 1991; Carlson et al., 1993).
Exposure of rat luteal cells to these oxidants resulted in oxidation and loss of fluidity in
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cellular membranes (Sawada and Carlson, 1991). Decreased membrane fluidity affects

cellular function including receptor binding and membrane-bound enzyme activity as
demonstrated by Wu et al. (1992), who suggested that superoxide radical production
inhibited LH stimulation of cyclic AMP and decreased activity of protein kinase A. In

pigs, FGFia depleted the CL of vitamin C, a natural antioxidant that prevents oxygen
radical formation (Petroff et al., 1999).

Although PGF2a signals cells through G-protein coupled receptors, other
prostaglandins such as the PGJ2 series are actively incorportated into the nucleus and
associate with nuclear proteins by unknown mechanisms (Narumiya et al., 1987). 15-

deoxy-12, 14- PGJ2 is the final metabolite of PGD2 degradation and is a potent ligand for

a nuclear hormone receptor known as peroxisome proliferator-activated receptor y
(PPAR-y). Peroxisome proliferator-activaded receptor-y is a member of a superfamily of
nuclear hormone receptors that function as ligand-dependent transcription factors

(Schoonjans et al., 1996). Three receptor subtypes of PPARs (termed a, 6, and y) have
been identified. The transcriptional activity of PPAR subtypes is enhanced by numerous
chemical compounds including fatty acids, selected prostaglandins, and peroxisome
proliferators(Schoonjans et al., 1996).

After activation, PPARs control expression of genes implicated in extra- and

intracellular lipid metabolism involved in peroxisomal P-oxidation pathways
(Schoonjans, 1996). Padilla et al. (2000) reported that PPAR-y agonist and PGJ2
produced cytotoxicity and antiproliferative effects on normal and malignant B cells.

Cytotoxicity was mediated via apoptosis as shown by positive annexin V staining and
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confirmed by DNA fragmentation detected using TUNEL assay. Prostaglandin I2, a key
prostaglandin during mouse implantation, also mediates its actions through activation of
PPARs(Hyunjung et al., 1999).

Prostaglandin Faa is a potent, bioactive compound. As such, its production and
metabolism must be tightly regulated. The lungs appear to play an important role in
inactivating prostaglandins. In the ewe, PGF2a in the blood stream has a half-life of less

than 1 min, since 99% of it is metabolized to 13,14-dihydro-15-keto-PGF2a(PGFM)in a
single passage through the lung (Hansel and Dowd, 1986). In the cow, only 16% of
PGF2a remained in the blood after three passages through the lung (Davis et al., 1984).

Prostaglandin F2a association with early embryonic loss

The first indications that PGF2a were involved in embryonic loss occurred in a

series of experiments in the "short cycle" cow at West Virginia University. In the
postpartum cow,the first ovulation is followed by a short luteal phase (short cycle) due to

premature release of PGF2a (Cooper et al., 1991). Cows with short luteal phase failed to

maintain pregnancy even when exogenous progestogen was provided (Breuel et al.,
1993b). Moreover, when good quality frozen-thawed embryos were transferred to
progestogen-supplemented animals on day 7 after estrus, pregnancy was maintain in 28%

of short cycle cows compared to 58% of cows with normal luteal phase (Butcher et al.,
1992). However, pregnancy rates did not differ when day-6 embryos from short cycle or

normal cycle cows were transferred to normally cycling recipients (Schrick et al., 1993),
suggesting that an improper uterine environment appears to play a role in lower survival

of embryos in cows with short cycle as compared to cows with normal luteal phases.
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Schrick et al. (1993) observed that concentrations of PGF2a in flushing media from cows
with short luteal phases were more than double those from cows with normal luteal

phases(636 ± 82 and 288 ± 90 pg/ml, respectively). Furthermore, embryo quality tended
to be negatively correlated with concentrations of PGFaa in the flushing media (r = -0.42;

P = 0.07). Thus, a direct negative effect of PGF2a may be implicated in lowering
embryonic survival as demonstrated in vitro in the mouse (Harper and Skames, 1972),
rabbit(Maurer and Beier, 1976), and rat(Breuel et al., 1993a).

Effects of PGF2a on embryo survival have been examined in several studies using
progestogen-supplemented cows to replace the regressing corpus luteum. Buford et al.

(1996) demonstrated that PGF2a was detrimental to embryonic survival when 15 mg of

PGF2a every 8 h were injected to nonlactating cycling beef cows during days 4 through 7
or 5 through 8 after insemination, but pregnancy rates remained high when lutectomy
(removal of the corpus luteum) was performed before PGF2a treatment begun. Similarly,
PGF2a administration to progestogen-supplemented beef cows on days 5 to 8
postbreeding reduced pregnancy rates (23%) compared to control (72%), whereas

lutectomy prior PGF2a administration tended to improve pregnancy rates (55%; Seals et

al., 1998). Removal of the corpus luteum eliminates oxytocin release from the corpus
luteum and blocks the positive feedback loop between oxytocin and PGF2a. As a result,
PGF2a concentration in the uterine lumen would remain low, allowing embryonic
development to occur. Furthermore, Seals et al.(1998) reported that detrimental action(s)

of PGF2a occurred during early embryonic development (days 5 to 8) since
administration of PGF2a during filamentous embryo development(beyond day 10)had no
effect on maintenance of pregnancy.
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Buford et al. (1996) demonstrated that postpartum cows bred at their first estrus

after weaning had higher pregnancy rates when lutectomy was used in conjunction with
flunixin meglumine (an inhibitor of COX-1 and COX-2), but lutectomy alone failed to
maintain pregnancy rates. The authors suggested that both premature secretion of PGFaa

and a factor released by the regressing corpus luteum may contribute to embryonic death
in the postpartum cow with a short luteal phase.

Oxytocin, which is released by large cells of the regressing corpus luteum in
response to PGFaa ,can increase secretion of PGF2a from the uterus (Milvae and Hansel,

1980). Lemaster et al. (1999) treated progestogen-supplemented cows with oxytocin
rather than PGF2a in the same type of experiment performed by Seals et al. (1998).
Administration of oxytocin on days 5 through 8 every 8 h reduced pregnancy rates to
33% compared to the control group (80%). In the same study, administration of flunixin

meglumine blocked the negative effects of oxytocin, while lutectomy did not; thus, the
role of oxytocin on embryonic death may involve further release of PGF2a rather than
having a direct negative effect on the embryo.

Numerous factors such as heat stress (Putney et al., 1989; Malayer et al., 1990),
nutrition (Butler, 1998), mastitis (Hockett et al., 2000), manipulation of the reproductive

tract during embryo transfer and artificial insemination (Odensvik et al., 1993), and plant

toxins (tall fescue; J. W. Oliver, personal communication) may contribute to early
embryonic losses (before day 8) through premature release of uterine luminal

concentrations of PGF2a in cattle. Administration of flunixin meglumine or ibuprofen
lysinate (inhibitors of COX-1 and COX-2) at time of embryo transfer improved
pregnancy rates in cows (Elli et al., 2001; Schrick et al., 2001). Furthermore, low-dose
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aspirin treatment improved implantation and pregnancy rates in human patients
undergoing in vitro fertilization and transfer (Rubinstein et al., 1999). Thus, in vivo and in

vitro studies have shown that PGF2a decreased embryonic development and survival in
several species.

Summary of literature

Early embryonic wastage results in reduced reproductive performance of cattle
and in a vast economic loss to beef and dairy producers. Several factors such as heat

stress, nutrition, mastitis, plant toxins and manipulation of the reproductive tract may
cause early embryonic death by induction of PGFaa release from the uterine
endometrium.

Presence of PGFia has been shown to be have direct and indirect negative effects
on embryo development; however, the exact mechanisms of PGF2a responsible of

lowering embryo survival are still unclear. Possible explanations may involve: 1)
stimulation of the apoptotic cascade (by up regulation of pro-apoptotic genes, activation
of endonucleases and/or formation of free radicals); and/or 2) unknown downstream
signals capable of phosphorylation/dephosphorylation of key regulatory proteins (such as
PKC) during compaction, which may lead to failures to either compact or form a
blastocoelic cavity.

The objective of this study was to determine any direct effect of PGF2a on

embryonic development of pre-compacted {in v/7ro-produced) and compacted {in vivoderived) bovine embryos.
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CHAPTER 3

EXPERIMENTAL PROCEDURES
Materials

Dimethyl sulphoxide (DMSG), polyvinyl alcohol (PVA), bovine serum albumin

(BSA), percoll, penicillamine, hypotaurine, epinephrine and the majority of reagents used

for in vitro production of bovine embryos were purchased from Sigma Chemical,Inc.(St.
Louis, MO). Tissue culture medium-199, gentamicin, and penicillin-streptomycin were
purchased from Specialty Media, Inc. (Phillipsburg, NJ). Prostaglandin F2a (PGF2a) and
prostaglandin E2(PGE2) were purchased from Cayman Chemical Company (Ann Arbor,
MI). Fetal bovine serum (FBS) was obtained from BioWhittaker (Walkersville, MD).
Follitropin-V was provided by Vetrepharm Canada, Inc. (London, Ontario) and

luteinizing hormone (LH) was obtained from the United States Department of
Agriculture (Beltsville, MD). Vigro was purchased from AB Technology, Inc.(Pullman,
WA). Embryos were generously donated by Trans Ova (Sioux City, lA), Em Tran
(Elizabethtown, PA), and Harrogate Genetics Inc. (Harrogate, TN). Ovaries were
purchased from Brown's Packing Plant (Gaffney, SC). Media (HEPES-TALP, IVF-

TALP, and SPERM-TALP; Parrish et al., 1988) and KSOM (Biggers et al., 2000), with

modifications generously provided by Dr. John Hasler, were prepared in the laboratory or
purchased from Specialty Media.
Preliminary experiment

A preliminary experiment was performed to determine if differences in embryo

development existed between KSOM media supplemented with either PVA (3 mg/mL,
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0.3%) or BSA (5 mg/mL, 0.5%). This study was performed due to a concern regarding
the possibility that PGF2a might bind to BSA present in KSOM culture medium utilized

during embryo development(Tanaka et al., 2000). A total of 187 in vzvo-derived glycerol
frozen bovine embryos were thawed using the three-step glycerol removal procedure (see
below). Morula stage embryos were cultured for 3 days in either KSOM supplemented
with PVA or BSA in a humidified atmosphere of 5.5% CO2, 7% O2, and 87.5% N2 at

38.5°C. After 3 days of culture (corresponding to day 9 of embryo development; Figure
2-2), blastocyst development was assessed using lETS guidelines for classification of
bovine embryos(see below).

Chi-square analysis was used to determine potential differences in development of
embryos (SAS 8.02, SAS Institute Inc., Gary, NC). There were no differences (F>0.10)
in proportion of morula continuing to blastocyst between KSOM-PVA (45.2%) or

KSOM-BSA (54.2%) culture media. As such, PVA was added to KSOM media during
PGF2a treatments to avoid any possible binding of PGF2a to BSA.

Preparation of prostaglandin stocks

Prostaglandin F2a (1 mg)and PGE2(1 mg) were solubilized in 10 mL of DMSG

each (Stock #1 of either PGF2a or PGE2, 1000 pg/mL). Then, 30 pL aliquots from each
prostaglandin solution were stored at -20 C° until needed. For each replicate of
Experiments 1 and 2, serial 10-fold dilutions of PGF2a stock #1 in KSOM-PVA were

made to yield desired concentrations of PGF2a- Likewise, stock #1 of PGE2 was diluted to

a final concentration of 5 ng/mL in 3 replicates of Experiment 1.
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Experimental Methods for Experiment 1
Oocyte collection

The procedures utilized for in vitro production of embryos (IVP) were

modifications of procedures previously described by Edwards and Hansen (1996).
Ovaries obtained from an abattoir were packaged in thermoses and contained within a

cooler during air transport to the laboratory. Upon arrival to the laboratory, ovaries were
immediately washed with warm water equilibrated to arrival temperature of ovaries
(generally between 28 to 30 C°). Extraneous tissue surrounding the ovaries was removed
and ovaries were washed with water an additional time.

For oocyte recovery, ovaries were held firmly by clamping the base of the ovary

with a hemostat and checkerboard incisions were made across follicles (approximately 38 mm in diameter) using a scalpel blade. Ovaries were vigorously washed in oocyte
collection medium (OCM) in order to remove cumulus oocyte complexes (COCs)
contained within the follicles. Collection medium was filtered and rinsed using an Emcon
Filter unit (Vet Concepts, Spring Valley, WI) until medium was clean. Medium

containing COCs was poured into a gridded culture dish where searching of oocytes was
accomplished. Cumulus oocyte complexes were transferred to an "X" plate with OCM

and washed four times to eliminate cellular debris. Cumulus oocyte complexes of good
quality were washed in oocyte maturation medium (OMM) and placed in groups of
approximately 50 COCs per well in a 4-well plate containing 500 pL OMM. Maturation
of oocytes was performed in an incubator at 5.5% CO2 in air at 38.5° C until time of

fertilization (approximately 22 h after placement in OMM). Maturation medium was
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equilibrated in the incubator (5.5% CO2 in air at 38.5°C) for a minimum of 5 h before
oocyte collection.

Sperm preparation and in vitrofertilization

At 22-24 h following oocyte collection, maturation medium from each well was

carefully removed and 25 ^1 of penicillamine/hypotaurine/epinephrine(PHE)and 500 pL
of fertilization medium (IVF-Talp) were added per well. Two straws of semen from two

bulls (140 Se5 and 140 Se55), known to have high motility as well as producing high
cleavage and blastocyst percentages were used to fertilize oocytes for every replicate of
the study. Briefly, semen straws were removed from liquid nitrogen tank and placed in
water at 36.7°C for 45 sec. Each straw was then emptied on top of a discontinuous
Percoll density gradient(2 mL 45% Percoll over 2 mL 90% Percoll contained in a 15 mL

conical tube) and sperm was centrifuged at 2200 rpm for 15 min in order to remove

excess extender, debris, and nonmotile sperm prior to fertilization. Sperm pellet present

at the bottom of the 90% fraction was collected and transferred to 10 mL Sperm-Talp and
centrifuged at 1100 rpm for 8 min. Supernatant was removed and sperm pellet resuspended in 500 pL of modified IVF-Talp. Sperm concentration was determined using a
hemocytometer and sperm was added to each well at a final concentration of 375,000
sperm per well. Lastly, oocytes and sperm were incubated at 5.5% CO2 in air at 38.5°C
for 18-22 h.
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In vitro culture

Approximately 18-22 h post fertilization, putative zygotes(PZ) were denuded of
cumulus cells by vortexing. Putative zygotes were transferred to a 15 mL conical tube

containing 500 pL of Hepes-Talp and vortexed for 4 min. Recovered putative zygotes

were washed 4 times in Hepes-Talp and once in KSOM-BSA before transferring groups
of approximately 50 zygotes to 4-well plates containg 500 pL of KSOM-BSA per well.
Zygotes were placed in a humidified atmosphere of 5.5% CO2, 7% O2, and 87.5% N2 at
38.5''C for 5 days.

On day 5 of embryonic development, 16- to 32-cell stage embryos were rapidly
washed in KSOM-PVA four times, evaluated for quality (normal shape, defined

blastomeres, extruded blastomeres, cytoplasmic fragmentation, even cytoplasm), evenly
sorted in four groups (formed by embryos of good quality), transferred to experimental
treatments in a 4-well plate, and placed in the incubator (5.5% CO2, 7% O2, and 87.5%

N2 at 38.5°C). Embryos remained in each treatment for 4 additional days (Figure 3-1).
Embryo development was assessed using lETS guidelines for classification of bovine
embryos.

Utilizing past studies on concentrations of PGF2a in uterine flush media, dilutions

of PGF2a were prepared to obtain 0, 1, 10 and 100 ng/mL (Figure 3-1). Treatments were
placed in each well of a 4-well plate (500 pL/well) and equilibrated in the incubator

(5.5% CO2,7% O2, and 87.5% N2 at 38.5°C)for at least 5 h prior to embryo placement.
For each replicate, two media samples from each treatment were collected to

determine concentrations ofPGF2a by radioimmunoassay. The first sample was collected
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Figure 3-1. Schematic illustration of experimental design for Experimentl. Treatments were control, 1
ng/mL (PGF-1), 10 ng/mL (PGF-10), and 100 ng/mL of prostaglandin F2„(PGF-100), and 5 ng/mL of
prostaglandin Ej(PGE-5).

on the day in which treatments began (day 5 of culture) and the second sample obtained
after determination of blastocyst development(day 9 of culture).

A total of 7 replicates were utilized for Experiment 1. In each replicate, embryos
at 16- to 32-cell stage receive one ofthe following culture treatments: 1)control(KSOMPVA; n= 168); 2) PGF-1 (1 ng/mL PGFia in KSOM-PVA; n= 143); 3) PGF-10 (10
ng/mL PGF2a in KSOM-PVA; n- 168); 4)PGF-100(100 ng/mL PGFja in KSOM-PVA;
n= 136), and 5) PGE-5 (5 ng/mL PGE2 in KSOM-PVA; n= 62; Figure 3-1).

Prostaglandin E2 is thought to be a "beneficial" prostaglandin during embryo
development (Diggers et al., 1978). Therefore, embryos cultured in media with addition

of 5 ng/mL of PGE2 were considered to be a positive control group (Gurevich et al.,
1993).

Experimental Methods for Experiment 2

In v/vo-derived glycerol-frozen bovine embryos were thawed utilizing the threestep glycerol removal procedure. Briefly, after removal from liquid nitrogen, straws
containing one or more embryos were held in air for 10 sec and then placed in a water
bath at 25°C for 45 sec. Straws were then emptied into an empty well of a 6-well plate.

Embryos were subsequently held and washed 5 min in each of the following solutions
(present in the same 6-well plate): 1) 1 mL of a solution made of 2 mL of IM sucrose

plus 4 mL 10% glycerol, 2) 1 mL of a solution made of 2 mL of IM sucrose plus 2 mL
10% glycerol plus 2 mL PBS (with 0.4% BSA), 3) 1 mL of a solution made of 2 mL of

IM sucrose plus 4 mL PBS (with 0.4% BSA), and 4) 1 mL of PBS. After washing in the

last solution, embryos were allowed to regain normal morphology for 30 min in Vigro
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holding medium and sorted by stage of development and quality according with the lETS

guidelines for classification of bovine embryos. For this study, a total of4 replicates were
used.

Schrick and coworkers(1993) reported 0.64 ng/mL of PGFaa in flush media from

short cycle cows. Based on these findings, concentrations of 0 (control, KSOM-PVA),
0.1, 1 and 10 ng/mL of PGFaa in culture medium were selected as treatments. Each

treatment was placed in a different well of a 4-well plate (500 pL/well) and then
maintained in the incubator (5.5% CO2, 7% O2, and 87.5% N2 at 38.5°C)for at least 5 h
before placement of embryos to allow equilibration of medium. At the same time, media
samples from each treatment were collected and stored at -20° C for determination of

PGF2a concentrations by radioimmunoassay.

Morula embryos (corresponding to day 6-7 of embryo development; Figure 2-2)
of quality grade 1, 2 or 3 were rapidly washed four times in KSOM-PVA and randomly
assigned to one of four treatments: 1) control (KSOM with PYA, n= 110); 2) PGF-0.1
(0.1 ng/mL PGF2a in KSOM-PVA, n=108); 3) PGF-1 (1 ng/mL PGF2a in KSOM-PVA,

n=109), 4)PGF-10(10 ng/mL PGF2a in KSOM-PVA, n=109; Figure 3-2) and placed in
the incubator(5.5% CO2,7% O2, and 87.5% N2 at 38.5°C).

After culturing embryos for 24 h in their respective treatment, embryos were

washed and placed in KSOM-BSA without PGF2a for an additional 48 h (Figure 3-2).
Evaluation of embryo development using lETS guidelines for classification of bovine
embryos was performed by experienced technicians uninformed oftreatments.
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Figure 3-2. Schematic illustration of experimental design for Experiment 2. Treatments were

control, 0.1 ng/mL (PGF-0.1), 1 ng/mL (PGF-1), and 10 ng/mL of prostaglandin Fj^CPGF-lO).

Radioimmunoassay for PGF2a concentrations in culture media

Concentrations of prostaglandin F2a in culture media samples were determined by
the procedure of Cooper et al. (1991) as modified by Schrick et al. (1993) for flash

samples. Inter- and intra-assay coefficients of variation for the PGFia assay were 14%
and 24%,respectively. For Experiment 1, concentrations of PGF2a in culture media at the

beginning (day 5) and at the end of culture period (day 9) yielded: 0.3 and 0.4 ng/mL for
control, 1.1 and 1.3 ng/mL for PGF-1, 9.6 and 11.0 ng/mL for PGF-10, and 80.9 and
103.5 ng/mL for PGF-100, respectively (Figure 3-3). Prostaglandin E2 concentrations at

the beginning of the treatments (0.27 ng/mL) were analyzed using the same RIA protocol
than PGF2a to verify absence of the latter during the culture period. For Experiment 2,
concentrations of PGF2a were 0.4, 0.5, 1.3, and 9.9 ng/mL for control, PGF-0.1, PGF-1,
and PGF-10, respectively (Figure 3-4).

Guide for classification of bovine embryos

The International Embryo Transfer Society (lETS) has published a guide for

classification of bovine embryos according to stage of development and quality (Manual
of the International Embryo Transfer Society. 1998. Third Edition). As mentioned, these
guidelines for development were used throughout both experiments.
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Early Blastocyst
Blastocyst
Expanded Blastocyst
Hatched Blastocyst
Expanded Hatched Blastocyst

6
7
8
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Statistical analysis

Data for Experiments 1 and 2 were analyzed to test for blastocyst development and

hatching rates using an incomplete block design and a randomized block design,
respectively. Analysis of variance was performed using mixed models (SAS 8.02, SAS
Institute Inc., Gary, NC)and contrasts were tested to identify differences across levels of
prostaglandin F2a on embryonic development. Analyses were then validated with Chisquare analysis(SAS 8.02, SAS Institute Inc., Gary, NG).
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CHAPTER 4

RESULTS AND DISCUSSION

The aim of this thesis was to investigate effects of prostaglandin F2a (PGF2a) on

development of in v/Yro-produced and in v/vo-derived bovine embryos. Utilization of
these types of bovine embryos provided a model to ascertain effects of PGF2a in culture

on pre-compacted {in v/Yro-produced) and compacted {in v/vo-derived) embryos.

Results from Experiment 1 indicated that culture of 16- to 32-cell pre-compacted
{in v/Yro-produced) embryos \vith 1, 10 or 100 ng/mL of PGF2a in the culture medium

reduced blastocyst development when compared to control (30.4 ± 5.3, 41.4 ± 5.1, 33.3 ±

5.3, and 51.8 ± 5.1 respectively, P=0.002, Figure 4-1). In addition, culture of embryos in
media containing 1 ng/mL of PGF2a had a more detrimental effect than addition of 10
ng/mL of PGF2a. However, hatching rates between treatments did not differ and neither

blastocyst development nor hatching rates differed between control and PGE2 treatments

{P>0.10). Thus, addition of PGF2a to culture medium had a direct negative effect on

development of 16- to 32-cell in v/Yro-produced embryos to blastocyst without altering
hatching rates.

These results agree with Breuel et al.(1993a) and Buuck (1997)in which addition
of PGF2a during in vitro culture decreased development of 8-cell rat embryos to

blastocyst. Furthermore, administration of PGF2a to progestogen-supplemented cows on

days 5 through 8 after mating decreased pregnancy rates (Seals et al., 1998) and embryo
quality and development in cattle (Hockett et al., 1998). Lemaster et al. (1999) reported
that administration of oxytocin on days 5 to 8 after mating to progestogen-supplemented

41

60

51.8

^ 50

41.4b

o

o

33.3b.<:

00 40

30.4

CD

^ 30
c
0)
o

K)

20

(D

I--

0-

10

Control

PGF-1

PGF-10

PGF-100

Treatments

Figure 4-1. Percentage of pre-compacted embryos that continued development to blastocyst in
Experiment 1. Treatments were control, 1 ng/mL (PGF-1), 10 ng/mL (PGF-10), and 100 ng/mL

of prostaglandin (PGF-100). ^b.cyaiues with different superscripts differ; P=0.002). Pooled
standard errors were ± 5.1, 5.3, 5.1 and 5.3 for control, PGF-1, PGF-10 and PGF-100,
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cows reduced pregnancy rates by stimulation of uterine release of PGF2a. Therefore,
reduction in development to blastocyst stage could be related to detrimental effects of

PGF2a on embryonic development prior to and/or during the compaction process.

Compaction, which in bovine embryos occurs at the 16- to 32-cell stage, is an
essential step of embryonic development in which formation of cell-to-cell adhesion

molecules allows blastomeres to differentiate into two distinctive cell populations (the
trophectoderm and the inner cell mass) and cavitation to occur (Watson et al., 1992).

Utilization of 16 to 32-cell embryos in Experiment 1 served as a model to investigate
PGF2a action(s) prior to or during compaction. Formation of gap junctions and cadherins

during compaction is considered a key event for continued development and blastocyst
morphogenesis (Fleming et al., 2001). In fact, injection of gap junction antisense RNA

decreased compaction and blastocyst formation in the mouse embryo (Bevilacqua et al.,
1989); whereas, mouse embryos lacking E-cadherin failed to generate a normal
trophectoderm and died before implantation (Laure et al., 1994; Riethmacher et al.,
1995).

The most understood mechanism by which PGF2a exerts its biological activity is
through receptor-mediated events. However, since detrimental effects of PGF2a on

embryonic development did not show a "dose response" change in development to

blastocyst, actions of PGF2a on bovine embryos may not involve receptor-mediated
events. Prostaglandin F2a binds to specific G-protein coupled receptors on targeted cells

(Sakamoto et al., 1994). Using the corpus luteum as an example, the ligand-receptor
binding activates phospholipase C that produces the hydrolysis of phosphatidylinositol
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bisphosphate (PIP2) into inositol triphosphate (IP3) and diacylglycerol (DAG). Then, IP3

induces the release of Ca"*^ from the endoplasmic reticulum increasing intracellular
concentrations of calcium, while DAG increases the affinity of PKC for Ca"^ (Davis et
al., 1987). The final outcome is a dramatic increase in intracellular levels of Ca"^ and

activation of PKC. Protein kinase C can then phosphorylate and regulate other proteins.
Protein kinase C-dependent excessive phosphorylation of connexin 43 inhibited gap
junction commimication and impaired ventricular conduction in the heart (Riley and
Behrman, 1991; Carlson et al., 1993). Increased intracellular levels of calcium by PGF2a

induced apoptosis in luteal cells during corpus luteum regression (Juengel et al., 1993).

Calcium stimulates Ca"^-dependent endonucleases to cut DNA into intemucleosomal
fragments, characteristic of the apoptotic process (Rueda et al., 1995). Furthermore,
Criswell (1995) also demonstrated that high intracellular levels of Ca"^ and addition of

Ca"^ ionophore 4-br-A23187 decreased gap junction communication. Thus, PGF2a may
exert negative effects on pre-compacted embryos by altering the formation and/or

function of gap junctions or by inducing apoptosis through activation of endonucleases.

Decreased intercellular communication and stimulation of apoptosis in early embryos

will result in impaired cellular differentiation and growth, ultimately resulting in
embryonic death.

Prostaglandins are also assumed to traverse membranes by simple diffusion.

However, prostaglandins are charged anions at physiological pH and may transverse

biological membranes inefficiently (Bito, 1975). This limited simple diffusion appears to
be augmented by a carrier mediated prostaglandin transport (PGT; (Shuster, 1998).
Prostaglandin transporter is a member of the 12-membrane-spanning superfamily of
44

transporters and has been cloned in rats and humans (Kanai et al., 1995; Lu et al., 1996).

Prostaglandin transporters from both species bind PGF2a, PGE2, and PGD2 with high
affinity and might mediate transepithelial transport of prostaglandins to cells (Lu et al.,

1996) and the efflux of newly synthesized prostaglandins from cells (Chan et al., 1998).

Clearance of prostaglandins may also be associated with PGT (Kanai et al., 1995). The
gene encoding PGT in humans is regulated by fluid mechanical stimuli in cultured

endothelial cells (Topper et al., 1998), suggesting that this is an inducible gene potentially
capable of responding to physiological stimuli in vivo. In the embryo, stretching of the
trophectoderm during cavitation could induce PGT especially for binding of PGE2.

Prostaglandin E2 has been shown to be involved in fluid accumulation during blastocyst
formation and hatching of the embryo from the zona pellucida (Diggers et al., 1978). It
may be possible that PGF2a could also bind and be internalized into individual

blastomeres through PGT that normally would bind PGE2.

Prostaglandin F2a might also enter the cells by simple diffusion or by binding to
PGT and activating peroxisome proliferator-activated receptors (PPAR) in the nucleus.

Peroxisome proliferator-activated receptors are a superfamily of nuclear hormone

receptors that function as a ligand-dependent transcription factors (Schoonjans et al.,
1996). The transcriptional activity of PPAR is enhanced by numerous chemical

compounds including fatty acids and prostaglandins (Schoonjans et al., 1996). After

activation, PPARs could then regulate transcription of developmentally important genes

involved in embryonic development(connexin 43, E-cadherin, Na''-K"'-ATPase pump)or
cause cytotoxicity via apoptosis. Padilla et al. (2000) reported that PPAR y agonist and
PGJ2 produced cytotoxicity and antiproliferative effects on normal and malignant B cells.
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Another action of PGF2a to decrease embryonic development could be the generation of

free oxygen radicals. Exposure of rat luteal cells to oxygen radicals induced apoptosis
(Riley and Behrman, 1991; Carlson et al., 1993) and loss of fluidity in cellular
membranes(Sawada and Carlson, 1991).

In Experiment 2, development to blastocyst of compacted {in v/vo-derived)
morula stage embryos (at least two stages beyond morula stage according to JETS
guidelines) did not differ between treatments (68.1% for control, 58.9% for PGF-0.1,

61% for PGF-1 and 60% for PGF-10,P>0.10, Figure 4-2). However, culture of embryos
in 0.1, 1, or 10 ng/mL of PGF2a for 24 h decreased hatching rates when compared to
control(24%,29.1%, 24.5%, and 44.5% respectively, P=0.05, Figure 4-3).
Thus, results from Experiment 2 indicated that continued development of

compacted {in v/vo-derived) morula embryos to the blastocyst stage was not altered by
addition of PGF2a to culture medium. However, PGF2a significantly reduced hatching
rates of in v/vo-derived morula. This is in agreement with Maurer and Beier (1976) who
reported that addition of PGF2a to culture medium directly decreased the ability of 8-cell
rabbit embryos to form expanded and hatched blastocyst, but had no effect on
development to early blastocyst. These findings are also consistent with in vivo studies in

which progestogen-supplemented cows administered PGF2a (days 5 through 8 after
estrous) had decreased pregnancy rates following transfer of morula stage embryos

(Hemandez-Fonseca et al., 1997). Whereas, transfer of blastocyst stage embryos to
progestogen-supplemented cows receiving PGF2a had pregnancy rates similar to controls

(E. Keith Inskeep, personal communication). Moreover, Schrick et al. (2001) reported
that administration offlunixin meglumine(a COX-1 and COX-2 inhibitor) at the time of
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embryo transfer improved pregnancy rates of morula and blastocyst stage embryos in
cattle. Thus, results from past and current studies indicate a negative effect of PGF2a on
embryonic development after compaction in cattle.

Although the exact mechanisms by which PGF2a is affecting embryonic

development at the morula stage are unknown and evidence of PGF2a receptors in

preimplantation bovine embryos have not been located in the literature, some modes of
action ofPGF2a on embryo development can be hypothesized. The reduction in hatching

rates of in v/vo-derived embryos may have resulted from an interruption of Na^ transport
across the trophectoderm epithelium by PGF2a. Kim and Yeoun (1983) observed a

reduction of Na"^-K"^-ATPase activity after treating luteal membranes with PGF2a (a
receptor mediated event). After compaction, accumulation of blastocoelic fluid within the
embryo causes expansion and hatching from the zona pellucida (Latham et al., 1999).

Localization of an active Na^-K"^-ATPase at the basolateral area of trophectoderm cell

assures movement of Na"*^ against a concentration gradient from the outside to the interior
of the embryo (Watson and Kidder, 1988); whereas, tight junction formation between
trophectoderm cells regulates paracellular transport of CP and controls leakage of the
nascent blastocoelic fluid (Fleming et al., 1989).

Possible explanation of deleterious effects of PGF2a on hatching rates would

involve disruption and/or dysfunction oftight junction or adherent junctions (E-cadherin)
between trophectoderm cells. Tsukita et al. (1991) observed an increase in paracellular

permeability of tight junctions due to elevated intracellular levels of Ca^. Furthermore,
Morgado-Diaz and de Souza (2000) reported that tyrosine phosphorylation causes

disassembly of adherent junctions in cell culture. Both, high intracellular levels of Ca"^
49

and protein phosphorylation are common features associated with the action of PGF2a on
target cells.

In conclusion, these studies suggest a direct negative effect of PGF2a on

embryonic development of pre-compacted {in vrfro-produced) and compacted {in vivo-

derived) bovine embryos. Prostaglandin F2a reduced the ability of 16- to 32-cell precompacted embryos to develop to blastocyst and may be related to deleterious actions of

PGF2a during or before the time of compaction (during the transition from 32-cell embryo
to compacted morula). Furthermore, PGF2a decreased hatching rates of compacted
morula embryos possibly through disruption/dysfunction of tight junctions or by

alterations in active transport of Na"^ during blastocoel formation. It was interesting to
note that different concentrations of PGF2a did not show a "dose response" effect on
development of embryos and hatching rates. Thus, detrimental effects of PGF2a on

continued embryonic development does not appear to be a receptor-mediated event in

either pre-compacted or compacted bovine embryos. Possible mechanisms of action may
involve alterations in gap junction and cell adhesion molecules functionality and/or
formation, induction of apoptotic mechanisms, or alterations in gene transcription during
embryonic development. Future research should be aimed at determining exact
mechanisms by which PGF2a alters embryonic development.
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